Kestra Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Kestra Advisory Services's BIO Position: Q3 2026 in Review
Kestra Advisory Services increased its Bio-Rad Laboratories Class A (BIO) stake by 11% in Q3 2026, buying an estimated $31.4K and bringing the position to 911 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.
Kestra Advisory Services first reported a position in BIO in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.76M in Q3 2021. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Kestra Advisory Services held 911 shares of Bio-Rad Laboratories Class A worth $344K as of Q3 2026.
- Kestra Advisory Services bought 90 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $31.4K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2839 holding.
- Kestra Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and has held it in 24 quarters since.
- Kestra Advisory Services's Bio-Rad Laboratories Class A position peaked at $1.76M in Q3 2021.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.